Different treatments are available for those with thyroid cancer. Some treatments are called standard. This means they are the currently used treatments. Some are being tested in clinical trials. A treatment clinical trial is a study meant to help improve current treatments or obtain information on new treatments.
When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. You may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment, while others are available during or after treatment.
Treatment options vary depending on your situation including the stage of the cancer and other factors that may be present.
Talk with your team about the approach that is best for you.
Standard treatments for thyroid cancer offered at Penn include:
Surgery
Surgery is the most common treatment of thyroid cancer. One of the following procedures may be used:
Radiation therapy
Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. Radiation therapy may be given after surgery to kill any thyroid cancer cells that were not removed.
Radioactive Iodine Therapy (RAI)
Follicular thyroid (cancer that forms in follicular cells in the thyroid. and papillary thyroid cancers (cancer that forms in follicular cells in the thyroid) are sometimes treated with radioactive iodine (RAI) therapy.
For imaging tests, the patient takes a small dose of radioactive iodine that collects in thyroid cells and certain kinds of tumors and can be detected by a scanner. To treat thyroid cancer, the patient takes a large dose of radioactive iodine, which kills thyroid cells. Radioactive iodine is given by mouth as a liquid or in capsules, by infusion, or sealed in seeds, which are placed in or near the tumor to kill cancer cells.
Higher doses than the amounts used to diagnose thyroid cancer are used. RAI is taken by mouth and collects in any remaining thyroid tissue, including thyroid cancer cells that have spread to other places in the body. Since only thyroid tissue takes up iodine, the RAI destroys thyroid tissue and thyroid cancer cells without harming other tissue. Before a full treatment dose of RAI is given, a small test-dose is given to see if the tumor takes up the iodine.
Chemotherapy
Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping the cells from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the spinal column, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). The way the chemotherapy is given depends on the type and stage of the cancer being treated.
Thyroid hormone therapy
Hormone therapy is a cancer treatment that removes hormones or blocks their action and stops cancer cells from growing. Hormones are substances made by glands in the body and circulated in the bloodstream. In the treatment of thyroid cancer, drugs may be given to prevent the body from making thyroid-stimulating hormone (TSH), a hormone that can increase the chance that thyroid cancer will grow or recur.
Also, because thyroid cancer treatment kills thyroid cells, the thyroid is not able to make enough thyroid hormone. Patients are given thyroid hormone replacement pills.
Targeted therapy
Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells without harming normal cells.
Tyrosine kinase inhibitor therapy is a type of targeted therapy being studied in the treatment of thyroid cancer. Tyrosine kinase inhibitors block signals needed for tumors to grow.
New types of treatment, are being tested in clinical trials at Penn. Patients can enter clinical trials before, during, or after starting their cancer treatment.
The Abramson Cancer Center hosts a wide range of materials and activities that provide education and support to address key areas of concern for cancer patients and their loved ones. We are proud that many of our innovative patient education programs have been recognized by national groups, including the National Cancer Institute's Cancer Patient Education Network.
Our educational materials and support activities help people deal with the physical and emotional consequences of a cancer diagnosis and treatment. They also assist patients and families to resume active lives after treatment.
Our support group meetings provide information on topics of ... read more Support
Different treatments are available for those with thyroid cancer. Some treatments are called standard. This means they are the currently used treatments. Some are being tested in clinical trials. A treatment clinical trial is a study meant to help improve current treatments or obtain information on new treatments.
When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. You may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment, while others are available during or after treatment.
Treatment options vary depending on your situation including the stage of the cancer and other factors that may be... read more Treatment
The Abramson Cancer Center of the University of Pennsylvania is committed to helping each cancer survivor find ways to enjoy life to the fullest. We have a nationally recognized program that focuses on the issues that survivors face, called "Living Well After Cancer™."
The LIVESTRONG™ Survivorship Center of Excellence, The Living Well After Cancer Program (LWAC) at the Abramson Cancer Center, directed by Linda A. Jacobs, PhD, RN, is a clinical, research, and education effort focused on early intervention and prevention of disease as the ultimate goal.
The multidisciplinary LWAC Program currently provides care and research opportunities to cancer survivors treated at Penn, the University of Pennsylvania Cancer Network hospitals, and through the Living Well
...
read more Living Well
In 2003 her doctors found a cancerous brain tumor, estimating that she had a year and a half to live. Sallie Nangeroni wanted the best neurosurgeon in the region. She came to HUP. Sally was rightfully scared. Her father died of brain cancer when he was just 40 years old, and her husband's brother had just passed away from a brain tumor. At the time she was diagnosed, Sallie just hoped that she would be able to see all three of her sons graduate from high school. Now, 7 years later, she has seen two of them graduate from college, with one now in medical school. Her next goal is to see her youngest son graduate from college next year.
Peter O'Dwyer, MD, professor of Hematology-Oncology and program director of Development Therapeutics in the Abramson Cancer Center, was interviewed on NBC10's 10! Show about Penn's work as part of the Stand Up to Cancer Dream Team... Read more